Alkem Labs is a stock to consider. It has recently broken out and is trading at all-time highs. Given the sustained buying interest and long build-up in the derivative data, Alkem Labs may continue to rise. The target is around 6,000 to 6,050, with a stop loss at 5,720.
Fund Manager Talk | Attractive risk-reward opportunity in midcap private banks, says Amey Sathe
Amey Sathe of Tata Asset Management sees opportunity in midcap private banks. He believes their valuations are compelling. Profitability is expected to improve in the
May 17, 2025